Anti-tissue factor antibodies, antibody-drug conjugates, and related methods
US12215167B2 · kind B2 · utility
0Cited by
106References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 29, 2022 |
| Grant date | Feb 4, 2025 |
| Priority date | — |
| Expiry date | Nov 7, 2042 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/7454
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are antibodies that specifically bind to human tissue factor (TF), anti-TF antibody-drug conjugates (ADCs), and compositions comprising the antibodies or ADCs. Also provided herein are methods of making and using the antibodies or ADCs, such as therapeutic and diagnostic methods.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.